(Q36054839)

11 August 2017

1 reference

title

Prognostic factors in lupus nephritis (English)

1 reference

11 August 2017

C C Mok

1 reference

11 August 2017

publication date

1 January 2005

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

page(s)

39-44

1 reference

A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

The prognosis of lupus nephritis in African-Americans: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Prognostic factors in lupus nephritis. Contribution of renal histologic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Late onset systemic lupus erythematosus in southern Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Demographic differences in the development of lupus nephritis: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

An epidemiologic analysis of end-stage lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Association of angiotensin-converting enzyme polymorphisms with systemic lupus erythematosus and nephritis: analysis of 644 SLE families

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Antiphospholipid antibodies are associated with an increased risk for chronic renal insufficiency in patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

The association between anti-ribosomal P antibodies and active nephritis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

The time-dependence of long-term prediction in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Long-term treatment of lupus nephritis with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Morbidity of systemic lupus erythematosus: role of race and socioeconomic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Cumulative rate of relapse of lupus nephritis after successful treatment with cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

Sequential therapies for proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203305LU2057OA

10.1191/0961203305LU2057OA

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference